Stockreport

Stock Market Today, April 28: Erasca Plunges After Patient Death in Early Cancer Drug Trial [Globe and Mail, The (Toronto, Canada)]

Erasca, Inc.  (ERAS) 
PDF Shares fell after the company disclosed a patient death from pneumonitis in its ERAS-0015 trial. Investors are watching for clearer safety data. Trading volume reached 5 [Read more]